A Study on a Blood-based Dual-target Test for CRC Detection

CompletedOBSERVATIONAL
Enrollment

1,378

Participants

Timeline

Start Date

October 21, 2022

Primary Completion Date

August 11, 2023

Study Completion Date

August 11, 2023

Conditions
Colorectal CancerColorectal Adenoma
Interventions
DIAGNOSTIC_TEST

Test of methylated NTMT1 and MAP3K14-AS1

A dual-target test kit to detect methylated NTMT1 and MAP3K14-AS1 in blood samples.

DIAGNOSTIC_TEST

FIT

Fecal immunochemical test(optional)

Trial Locations (1)

200433

Changhai Hospital, Shanghai

All Listed Sponsors
collaborator

The Second Hospital of Hebei Medical University

OTHER

collaborator

Qilu Hospital of Shandong University

OTHER

collaborator

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER

collaborator

Henan Provincial People's Hospital

OTHER

lead

Changhai Hospital

OTHER